LifeArc Ventures is the venture investment arm of LifeArc, a self-funded medical research charity. It invests in early-stage, science-led therapeutics and healthtech companies from seed to Series B, providing scientific insight, advice, and venture funding, with financial returns reinvested into LifeArc's charitable mission.
41% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (4 deals in the last 12 months vs 6 prior). Their most common stage is series-a (55% of deals). Average disclosed round size is $64.7M (across 18 rounds with reported amounts).
Portfolio
22
Fund Size
—
Top Stage
Series A
Last 12 Mo
4
Team
Dr Ian Gilham
Chair of Board of Trustees
Sam Barrell
Chief Executive Officer (CEO)
Stéphane Maikovsky
Deputy Chief Executive Officer and Chief Financial Officer
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 RQ Biotechnology | Series A | $115M | Jun 2026 |
 Cytospire Therapeutics | Series A | — | May 2026 |
 Tribune Therapeutics | Series A | — | Jan 2026 |
 Exciva | Series B | — | Jan 2026 |
| Cytospire Therapeutics | Series A | $61M | Jan 2026 |
| RQ Biotechnology | Series A | $115M | Jan 2026 |
 GlycoEra | Series B | $130M | May 2025 |
| Tribune Therapeutics | Series A | — | Apr 2025 |
 Hillstar Bio | Series A | $67M | Mar 2025 |
| Exciva | Series B | $59M | Jan 2025 |
| HHillstar | Series A | $67M | Jan 2025 |
 Maxion | Series A | $72M | Jan 2025 |
| MMaxion Therapeutics Ltd. | Series A | $72M | Jan 2025 |
| Hillstar Bio | Series A | $67M | Jan 2025 |
 FLUID BIOMED | Series A | $27M | Dec 2024 |
 Ozlo Sleep | Unknown | $12M | Oct 2024 |
| MMaxion Therapeutics Ltd. | Series A | $16M | Feb 2024 |
| FLUID BIOMED | Series A | $27M | Jan 2024 |
| OOzlo | Unknown | $12M | Jan 2024 |
| OOxford Cancer Analytics (OXcan) | Seed | — | Jan 2023 |
 Climb Bio | Series B | $60M | May 2021 |
| EEliem Therapeutics | Series B | $60M | May 2021 |
| BBrainWaveBank | Seed | — | Jul 2020 |
 Springworks | Series B | $125M | Jan 2019 |
 Ikarovec | Seed | — | — |
Top Co-Investors
Last updated: 20 October 2026